131 related articles for article (PubMed ID: 8511729)
1. Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation.
Rajakulasingam K; Polosa R; Lau LC; Church MK; Holgate ST; Howarth PH
Thorax; 1993 Apr; 48(4):324-9. PubMed ID: 8511729
[TBL] [Abstract][Full Text] [Related]
2. The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage.
Rajakulasingam K; Polosa R; Lau LC; Church MK; Holgate ST; Howarth PH
Clin Exp Allergy; 1992 Jul; 22(7):717-23. PubMed ID: 1387041
[TBL] [Abstract][Full Text] [Related]
3. Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers.
Rajakulasingam K; Polosa R; Holgate ST; Howarth PH
J Physiol; 1991 Jun; 437():577-87. PubMed ID: 1890650
[TBL] [Abstract][Full Text] [Related]
4. Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.
Austin CE; Foreman JC
Br J Clin Pharmacol; 1994 Jan; 37(1):33-7. PubMed ID: 8148216
[TBL] [Abstract][Full Text] [Related]
5. Nasal effects of bradykinin and capsaicin: influence on plasma protein leakage and role of sensory neurons.
Rajakulasingam K; Polosa R; Lau LC; Church MK; Holgate ST; Howarth PH
J Appl Physiol (1985); 1992 Apr; 72(4):1418-24. PubMed ID: 1317373
[TBL] [Abstract][Full Text] [Related]
6. The contribution of histamine to the action of bradykinin in the human nasal airway.
Austin CE; Dear JW; Neighbour H; Lund V; Foreman JC
Immunopharmacology; 1996 Sep; 34(2-3):181-9. PubMed ID: 8886862
[TBL] [Abstract][Full Text] [Related]
7. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.
Svensson C; Alkner U; Pipkorn U; Persson CG
Eur J Clin Pharmacol; 1994; 46(1):59-65. PubMed ID: 8005188
[TBL] [Abstract][Full Text] [Related]
8. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.
Maniscalco M; Sofia M; Faraone S; Carratù L
Allergy; 2000 Aug; 55(8):757-61. PubMed ID: 10955702
[TBL] [Abstract][Full Text] [Related]
9. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
[TBL] [Abstract][Full Text] [Related]
10. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
11. The effect of platelet-activating factor on the responsiveness of the human nasal airway.
Austin CE; Foreman JC
Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870
[TBL] [Abstract][Full Text] [Related]
12. The temporal relationship between the neural and vascular actions of kallidin within the nose.
Rajakulasingam K; Lau LC; Polosa R; Church MK; Holgate ST; Howarth PH
Mediators Inflamm; 1993; 2(3):217-23. PubMed ID: 18475525
[TBL] [Abstract][Full Text] [Related]
13. Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs.
Corrado OJ; Ollier S; Phillips MJ; Thomas JM; Davies RJ
Br J Clin Pharmacol; 1987 Sep; 24(3):283-92. PubMed ID: 3117084
[TBL] [Abstract][Full Text] [Related]
14. A study of the action of bradykinin and bradykinin analogues in the human nasal airway.
Austin CE; Foreman JC
J Physiol; 1994 Jul; 478 ( Pt 2)(Pt 2):351-6. PubMed ID: 7965850
[TBL] [Abstract][Full Text] [Related]
15. Nasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative study.
Corrado OJ; Gould CA; Kassab JY; Davies RJ
Thorax; 1986 Nov; 41(11):863-8. PubMed ID: 3547756
[TBL] [Abstract][Full Text] [Related]
16. Effects of leukotriene D
Zhu Z; Xie Y; Guan W; Gao Y; Xia S; Huang R; Zhong N; Zheng J
Clin Respir J; 2018 Feb; 12(2):587-594. PubMed ID: 27696764
[TBL] [Abstract][Full Text] [Related]
17. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.
Greiff L; Andersson M; Svensson C; Nilsson M; Erjefält I; Erjefält JS; Persson CG
Allergy; 1995 Jul; 50(7):593-7. PubMed ID: 8588693
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
[TBL] [Abstract][Full Text] [Related]
19. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical phenylpropanolamine on nasal secretion and nasal airway resistance after histamine challenge in man.
Löth S; Bende M
Clin Otolaryngol Allied Sci; 1985 Feb; 10(1):15-9. PubMed ID: 4006263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
